RIP assay in A375 cells (Figure 5B) provided confirmation that SMARCE1 also could bind to cyclin D1 pre-mRNA, indicating the important role of SMARCE1 in regulating the alternative splicing of cyclin D1 gene in skin cancer cells. Here, CCND1 is linked to skin neoplasm.